CSG’s Eurosatory Offensive: New Contracts, New Vehicles, Same Old Stock Weakness
20.06.2026 - 11:14:04 | boerse-global.de
The contrast between what CSG announced on the Eurosatory show floor and how its shares finished the week could hardly be starker. The Czech defence group unveiled a strategic propulsion partnership for Ukraine and rolled out the TADEAS 4x4 armoured vehicle in Paris on 15 June, yet the stock ended Friday at €14.28 – a meagre 0.14% gain that leaves it dangerously close to its yearly low.
Two Deals, One Overarching Message
AviaNera Technologies, a CSG subsidiary, signed a strategic cooperation agreement with Ukrainian Armor LLC on the opening day of the defence exhibition. The pact covers propulsion units for Ukrainian rockets and unmanned systems across multiple power classes. The companies plan to establish joint production capacity and localise key technologies in Ukraine, acknowledging that engine supply has become a “production bottleneck” for drones and guided missiles.
The same morning, Tatra Defence presented the TADEAS 4x4, a new modular armoured platform that shares components with the third-generation Tatra Force range. Designed to carry payloads of five to six tonnes and a gross vehicle weight of up to 25 tonnes, the vehicle can be configured as a command post, ambulance or pick-up for air-defence systems. Tatra stressed that the TADEAS is an extension of its existing family, not a wholly new project – a pitch aimed at armies seeking logistics standardisation.
Should investors sell immediately? Or is it worth buying CSG?
Technicals Flash Warning Signs
None of that momentum transferred to the stock price. Shares closed Friday within 4.6% of the 2026 trough of €13.65, set on 4 May. The distance to the 52-week high of €36.05 is a staggering 60%. Over the past 30 days, CSG has shed nearly a quarter of its value.
The relative strength index sits at 35.3, indicating weak upward momentum without yet entering oversold territory. The 50-day moving average of €17.56, which would mark the first technical recovery signal, remains far out of reach. Meanwhile, the 30-day annualised volatility has climbed to around 56%, confirming CSG’s status as a high-beta defence name that lacks a stable floor.
Fundamentals Tell a Different Story
The gap between operational performance and market sentiment is wide. In the first quarter of 2026, CSG posted revenue of €1.544 billion – a 13.8% year-on-year advance – and operating EBIT of €372 million, up 8.7%, translating into a margin of 24.1%. The order book has swollen to €17 billion, and management has confirmed its full-year guidance of up to €7.6 billion in sales with an operating margin around 24%.
Yet investors appear to be taking a show-me stance. Product launches and partnerships do not automatically convert into order inflows, and the real test will come with the next quarterly reports. The first major checkpoint is the half-year results, due on 7 August. Until then, the stock’s path of least resistance remains lower, with the €13.65 support level acting as the last line of defence before what would be uncharted lows for the year.
Ad
CSG Stock: New Analysis - 20 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
